Small Cap Feast
Small Cap Feast – 13 March 2019
Set Menu AIM:
Total number of AIM Companies (Incl Susp): 905
Total number of AIM Companies trading: 835*
* As at 11 March 2019
Set Menu NEX Growth:
Total number of NEX Growth Market Companies (Incl Susp): 89*
Total number of NEX Growth Market Companies trading: 87*
* As at 11 March 2019
Set Menu Standard List:
Total number of Standard List Companies (Incl Susp): 161*
Total number of Standard List Companies trading: 142*
* As at 11 March 2019
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
What’s Cooking in the IPO Kitchen?
Main Market (Premium)
US Solar Fund, a newly-established investment company focused on investing in solar power assets mainly in the US, looking to raise $250m at $1. Expected 20 March
Techniplas –global producer and support services company providing highly engineered and technically complex components, making the supply chain to original equipment manufacturers more efficient. FYDec17 rev $515m.
Diaceutics, a data analytics and implementation services company which services the global pharmaceutical industry, is looking to join AIM late March, offer TBC.
Rumours & Speculation
Proactive Investors reports that London-based investment management firm M12 Global. intends to list “on one of the main London stock exchanges later this year to fill over $3bn worth of demand for credit within the Mayfair 101 portfolio over the next five years.”
Franchise Brands (FRAN.L) 68p £52.7m
FYDec18 results from the international multi-brand franchisor.
“A strong performance, ahead of expectations, as we start to unlock Metro Rod’s potential “.
Revenue increased by 43% to £35.5m (2017: £24.9m).
Fee income increased by 41% to £17.9m (2017: £12.7m).
Adjusted EBITDA increased by 37% to £3.7m (2017: £2.7m).
Final dividend of 0.46p per share proposed (2017: 0.33p per share), giving a 34% increase in the total dividend for the year to 0.67p per share .
“2019 has started encouragingly, with a good trading performance across the networks in the first two months of the year and order intake at Metro Rod ahead of 2018. The level of franchise enquiries at ChipsAway, Ovenclean and Barking Mad is also significantly ahead of last year. We therefore look forward to the year ahead with confidence.”
EVR Holdings (EVRH.L) 4.4p £57.6m
The creator of virtual reality music content has entered into:
UMmusic licensing agreements with PI Ltd, a part of the Universal Music Publishing Group, one of the world’s largest music publishers.
Publishing agreement with SACEM, the Society of Authors, Composers, and Publishers of Music, who represents the rights of authors and composers in France, such as David Guetta and Mylene Farmer.
ASCAP, the American Society of Composers, Authors and Publishers, representing the public performances of their members’ musical copyright in the United States.
BMI, Broadcast Music Inc, collecting and distributing public performance license fees on behalf of their songwriter, composer and music publisher members across the United States, representing the rights of songwriters such as Lady Gaga and Childish Gambino.
Walcom Group (WALG.L) 0.37p £0.26m
Walcom announced it is in negotiations regarding the proposed disposal of its entire interest in its subsidiary Walcom Bio-Chem (Thailand) Company Limited, to the General Manager of, and 40% shareholder in, Walcom Thailand. As announced previously, Walcom’s working capital position remains severely constrained. The board of the Company now believes that without further action, the Company may not be able to meet its liabilities as they fall due by the middle of April 2019. The directors of Walcom therefore believe that the Proposed Disposal is a necessary action to ease the Company’s immediate short-term working capital position. If the Proposed Disposal is completed, it is expected that the net proceeds of the disposal will be received prior to the middle of April 2019. The Company continues to consider all other possible options to improve the Company’s working position.
Coral Products (CRU.L) 11.75p £9.7m
The specialist in the design, manufacture and supply of plastic products, announces that its new 360 degree plastic recycling plant will be officially opened at Haydock this morning by Councillor Lynn Clarke, cabinet member at St Helens Council with responsibility for its green, smart and sustainable portfolio.
With a capacity of a ton an hour it will process Polypropylene, HD and PVC plastic materials. The subsequent material will be used to manufacture new products through the company’s injection moulders and extrusion profile machinery.
There has been a high level of interest in the plant from local authorities.
“It is an exciting time at Coral. Recycling and the Environment is high on Coral’s agenda, and as such we are proud to introduce a bespoke recycling unit into our business.”
Everyman Media (EMAN.L) 181p £128.5m
FY Jan 19 results.
Revenue for the year up 27.7% to £51.9m (2017: £40.6m)
Adjusted EBITDA increased 38.2% to £9.2m (2017: £6.6m)
Admissions up 25% on last year to 2.8m (2017: 2.2m)
A further 5 new Everyman venues opened in the last 12 months, growing the estate to 26 sites and 84 screens as at 12 March 2019
Everyman has a further 14 committed venues, of which 7 are expected to open in 2019
By the end of 2018, Everyman had become the fifth largest cinema business in the UK
EKF Diagnostics (EKF.L) 32p £146m
FYDec18 results from the point of care diagnostics business.
Revenue up 2% to £42.5m (2017: £41.6m)
Gross profit broadly flat at £22.7m (2017: £22.9m)
Adjusted EBITDA up 15% to £10.7m (2017: £9.3m)
PBT £12.2m (2017: £4.3m), over 2.8 times higher
Cash generated from operations of £9.9m (2017: £10.1m)
“We are confident that we will continue to make progress in 2019. Trading in the first quarter to date has been satisfactory, in line with management expectations.”
Staffline Group (STAF.L) 1,000p £279m
Staffline, the Recruitment and Training group, announced that its PeoplePlus division has been successful in the latest round of Education and Skills Funding Agency’s European Social Fund competition, securing contracts worth a total of £35m over a 27-month period, commencing in April 2019. The contracts cover 10 Local Enterprise Partnership areas across England.
PeoplePlus currently delivers equivalent European Social Fund contracts worth £14m, so these wins represent an increase of 250% and make PeoplePlus the largest provider of Skills Support for the Unemployed with a market share of c.47%.
Charles Taylor (CTR.L) 197.25p £148.5m
FYDec18 results from the International loss adjuster.
Consolidated existing claims services related capabilities to create an integrated claims services business with global scale and material growth prospects
Built a sizeable, sustainable InsureTech business with rapid growth prospects
Revenue £263.6m increased by 25%. Adjusted PBT £22.3m increased by 48%.
“Charles Taylor has had a good start to 2019. We anticipate that our full year performance will be in-line with market expectations.”
Hardide (HDD.L) 48p £23.3m
“The provider of advanced surface coating technology, is pleased to announce that preliminary tests indicate that Hardide nanostructured chemical vapour deposition (CVD) coating can extend the life of steam turbine blades through significantly enhanced resistance to water droplet erosion (WDE) and solid particle erosion.
The tests, carried out by the National Physical Laboratory and the University of Manchester, assessed the effectiveness of the Hardide coating as protection from WDE and cracking on FV520B last stage turbine blades.
After 90 hours of exposure to WDE (up to 1.2×108 water droplet impacts) Hardide-A coated 410 stainless steel samples showed almost no discernible damage in the central zone. The uncoated 410 stainless steel samples suffered major damage with a 200 microns deep scar across the sample face after a much shorter exposure of just 7 hours.”
Altus Strategies (ALS.L) 3.5p £6.2m
“The Africa focused exploration project generator, announces that it has granted ASX-listed Indiana Resources Ltd a thirty day extension to the exclusivity period to now end on 6 May 2019, for completing due diligence on the Company’s Lakanfla and Tabakorole gold projects. Lakanfla is located 6km southeast of the Sadiola gold mine in western Mali and Tabakorole is located in southern Mali.
The Extension is further to the announcement by the Company of 7 Feb 2019 in respect of the signing of a non-binding Terms Sheet for a joint venture with Indiana on the Projects, whereby subject to entering a definitive agreement with Altus, Indiana will have the option to earn up to an 85% interest in Legend Mali (BVI) II Inc., a wholly owned subsidiary of the Company and which holds a 100% interest in the Projects.
Indiana may earn its interest in the Projects by funding their exploration and development and in return the Company will receive milestone based cash and equity in Indiana, retain a 2.5% Net Smelter Return royalty on the Projects”.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email firstname.lastname@example.org with “unsubscribe me”.